We are live on ! Find out more
FLC

Fifth Lane Capital Portfolio holdings

AUM $1.63M
1-Year Est. Return 7.5%
This Fund
S&P 500
This Quarter Est. Return
+11.92%
1 Year Est. Return
+7.5%
3 Year Est. Return
+79.98%
5 Year Est. Return
10 Year Est. Return
AUM
$192M
AUM Growth
+$33.1M
Cap. Flow
+$36.3M
Cap. Flow %
18.93%
Top 10 Hldgs %
70.32%
Holding
475
New
116
Increased
20
Reduced
19
Closed
248
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUS.WS
101
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
$12K 0.01%
+117,295
New +$19.4K
UHGWW
102
DELISTED
United Homes Group Warrant
UHGWW
$11K 0.01%
47,001
-25,079
-35% -$4.1K
CSLMR
103
DELISTED
CSLM Acquisition Corp. Right
CSLMR
$11K 0.01%
+100,000
New +$10.9K
DNA.WS
104
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$11K 0.01%
+14,631
New +$10K
LOCC.WS
105
DELISTED
Live Oak Crestview Climate Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOCC.WS
$11K 0.01%
31,618
CDIOW icon
106
Cardio Diagnostics Holdings Inc Warrant
CDIOW
$892K
$10K 0.01%
62,200
IGTAR
107
DELISTED
Inception Growth Acquisition Limited Rights
IGTAR
$10K 0.01%
126,700
ENERR
108
DELISTED
Accretion Acquisition Corp Right
ENERR
$10K 0.01%
125,000
IFIN.WS
109
DELISTED
InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share
IFIN.WS
$10K 0.01%
+104,960
New +$8.64K
DUETW
110
DELISTED
DUET Acquisition Corp. Warrant
DUETW
$10K 0.01%
192,000
AFARW
111
DELISTED
Aura FAT Projects Acquisition Corp Warrant
AFARW
$10K 0.01%
+250,000
New +$19.1K
CLRCR
112
DELISTED
ClimateRock Right
CLRCR
$9K ﹤0.01%
69,443
AEAEW
113
DELISTED
AltEnergy Acquisition Corp Warrant
AEAEW
$9K ﹤0.01%
49,331
CCV.WS
114
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$9K ﹤0.01%
100,091
-64,463
-39% -$12.9K
GENQW
115
DELISTED
Genesis Unicorn Capital Corp. Warrants
GENQW
$9K ﹤0.01%
146,400
JMACW
116
DELISTED
Maxpro Capital Acquisition Corp. Warrants
JMACW
$9K ﹤0.01%
77,427
STRE.WS
117
DELISTED
Supernova Partners Acquisition Company III, Ltd. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
STRE.WS
$9K ﹤0.01%
+84,826
New +$10.1K
MSSAR
118
DELISTED
Metal Sky Star Acquisition Corporation Right
MSSAR
$8K ﹤0.01%
+104,707
New +$7.91K
RFACR
119
DELISTED
RF Acquisition Corp. Rights
RFACR
$8K ﹤0.01%
100,000
EVGRW
120
DELISTED
Evergreen Corporation Warrant
EVGRW
$8K ﹤0.01%
+132,970
New +$8.19K
CNGLW
121
DELISTED
Canna-Global Acquisition Corp Warrant
CNGLW
$8K ﹤0.01%
336,723
AAC.WS
122
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$8K ﹤0.01%
+71,501
New +$12.3K
DAOOW
123
DELISTED
Crypto 1 Acquisition Corp Warrants
DAOOW
$8K ﹤0.01%
+82,088
New +$7.99K
ZVSAW
124
DELISTED
ZyVersa Therapeutics, Inc. Warrants
ZVSAW
$8K ﹤0.01%
62,500
+25,000
+67% +$3.23K
GDSTR
125
DELISTED
Goldenstone Acquisition Limited Rights
GDSTR
$7K ﹤0.01%
41,572
+2
+0%

Similar funds

Fifth Lane Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Fifth Lane Capital held 475 positions worth $192M, up 21% from $159M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Fifth Lane Capital deployed $36.3M of net new capital in Q3 2022, opening 116 new positions and adding to 20 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 140,000 shares worth $21.2M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 14% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Churchill Capital Corp VII Class A Common Stock, an estimated $517K trimmed.

  • Fifth Lane Capital's largest Q3 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 140,000 shares worth $21.2M.
  • Fifth Lane Capital added most to Citrix Systems Inc in Q3 2022, an estimated $33M increase.
  • Fifth Lane Capital's biggest Q3 2022 reduction was Churchill Capital Corp VII Class A Common Stock, cutting an estimated $517K.
  • Fifth Lane Capital fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $6.89M.
  • Fifth Lane Capital's ten largest holdings make up 70% of its $192M portfolio in Q3 2022.
  • Fifth Lane Capital opened 116 new positions and closed 248 in Q3 2022.
  • Fifth Lane Capital's portfolio value rose 21% quarter-over-quarter to $192M.

Based on Fifth Lane Capital's 13F filing for Q3 2022, filed 14 Nov 2022.